Sign up for free insights newsletter
EV

Evolent Health Inc

EVHUnited States

Need professional-grade analysis? Visit stockanalysis.com

$2.25
-12.79%
End of day
Market Cap

$333.80M

P/E Ratio

N/A

Employees

4,200

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.65-1.55-1.36-1.50
Calmar-2.21-1.24-0.94-1.35
Sharpe-1.09-1.17-1.02-1.09
Omega0.620.580.750.66
Martin-3.82-1.68-1.65-2.20
Ulcer22.3553.8344.4642.05

Evolent Health Inc (EVH) Price Performance

Evolent Health Inc (EVH) trades on United States in USD. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at $2.25, down 12.79% from the previous close.

Over the past year, EVH has traded between a low of $2.25 and a high of $11.79. The stock has lost 76.2% over this period. It is currently 80.9% below its 52-week high.

Evolent Health Inc has a market capitalization of $333.80M.

About Evolent Health Inc

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$1.96B
EBITDA
$88.22M
Profit Margin
-28.49%
EPS (TTM)
-5.07
Book Value
3.72

Technical Indicators

52 Week High
$12.07
52 Week Low
$2.25
50 Day MA
$3.35
200 Day MA
$6.73
Beta
0.23

Valuation

Trailing P/E
N/A
Forward P/E
16.98
Price/Sales
0.18
Price/Book
0.80
Enterprise Value
$1.58B